Captor Therapeutics Spolka Akcyjna
WSE:CTX.WA
105 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 39.257 | 75.704 | 71.036 | 117.943 | 10.654 | 12.342 | 2.448 | 1.587 |
| Short Term Investments
| 0 | 0 | 19.854 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 39.257 | 75.704 | 90.89 | 117.943 | 10.654 | 12.342 | 2.448 | 1.587 |
| Net Receivables
| 38.254 | 6.37 | 9.678 | 11.706 | 1.754 | 1.88 | 4.024 | 0.515 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0.471 | 0.319 | -0.515 |
| Other Current Assets
| 0.576 | 0.088 | 9.452 | 11.638 | 2.569 | 0.472 | 0.317 | 0.007 |
| Total Current Assets
| 78.087 | 88.648 | 101.324 | 130.555 | 13.246 | 14.694 | 6.789 | 2.109 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 8.846 | 8.113 | 10.666 | 12.612 | 12.198 | 10.355 | 11.174 | 2.873 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0.415 | 0.309 | 0.781 | 0.36 | 0.321 | 0.237 | 0.086 | 0.142 |
| Goodwill and Intangible Assets
| 0.415 | 0.309 | 0.781 | 0.36 | 0.321 | 0.237 | 0.086 | 0.142 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0.012 | 0.012 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | -0.012 | -0.012 | 0 |
| Other Non-Current Assets
| 0.149 | 0.224 | 0.229 | 0.014 | 0.014 | 0.012 | 0.012 | 0 |
| Total Non-Current Assets
| 9.41 | 8.646 | 11.676 | 12.986 | 12.533 | 10.604 | 11.272 | 3.015 |
| Total Assets
| 87.497 | 97.294 | 113 | 143.541 | 25.779 | 25.298 | 18.061 | 5.124 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 2.649 | 6.503 | 4.298 | 2.296 | 2.364 | 1.969 | 1.68 | 0.363 |
| Short Term Debt
| 2.747 | 2.531 | 3.717 | 5.241 | 5.734 | 4.551 | 3.484 | 1.262 |
| Tax Payables
| 0 | 0.955 | 1.349 | 0.896 | 0 | 0.567 | 0.394 | 0.13 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 8.681 | 0.394 | 0.13 |
| Other Current Liabilities
| 14.635 | 16.742 | 4.028 | 7.934 | 11.908 | 8.147 | 1.676 | 1.52 |
| Total Current Liabilities
| 20.031 | 26.731 | 13.392 | 16.367 | 20.006 | 15.234 | 7.234 | 3.535 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 2.89 | 1.247 | 3.235 | 2.94 | 6.712 | 5.733 | 7.373 | 1.442 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.102 | 0.096 | 0.051 | 0.033 | 0.065 | 0.053 | 0.023 | 0.003 |
| Total Non-Current Liabilities
| 2.992 | 1.343 | 3.286 | 2.973 | 6.777 | 5.786 | 7.396 | 1.445 |
| Total Liabilities
| 23.023 | 28.074 | 16.678 | 19.34 | 26.783 | 21.02 | 14.63 | 4.98 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.55 | 0.465 | 0.417 | 0.413 | 0.359 | 0.359 | 0.359 | 0.359 |
| Retained Earnings
| -203.112 | -164.686 | -94.102 | -58.208 | -25.636 | -12.942 | -4.637 | -0.215 |
| Accumulated Other Comprehensive Income/Loss
| 26.542 | 24.558 | 19.976 | 11.965 | 24.273 | 16.861 | 7.709 | 0 |
| Other Total Stockholders Equity
| 240.494 | 208.883 | 170.031 | 170.031 | 16.292 | 0 | 0 | 0 |
| Total Shareholders Equity
| 64.474 | 69.22 | 96.322 | 124.201 | -1.004 | 4.278 | 3.431 | 0.144 |
| Total Equity
| 64.474 | 69.22 | 96.322 | 124.201 | -1.004 | 4.278 | 3.431 | 0.144 |
| Total Liabilities & Shareholders Equity
| 87.497 | 97.294 | 113 | 143.541 | 25.779 | 25.298 | 18.061 | 5.124 |